Media Release
Credabl successfully completes second public term ABS transaction and debuts in international capital markets
Credabl is pleased to announce the successful completion of its second public term asset-backed securities (ABS) transaction, raising $450 million. This milestone marks the company's inaugural foray into international capital markets, following its debut term transaction in August 2024, which was supported by Australian domestic investors.
The transaction, Credabl ABS 2025-1, is backed by a diversified portfolio of loans including commercial real estate (practice premises), equipment, goodwill (practice purchase), fitouts and motor vehicles, originated for Australian medical, dental, veterinary and allied healthcare professionals.
This deal represents a key evolution in Credabl's wholesale funding strategy, expanding its capital base and enhancing the business' capacity to scale with growing demand from the healthcare sector. The inclusion of offshore investors not only validates the quality of Credabl's loan book and underwriting standards but also underscores the broader market’s confidence in the company’s business model and future trajectory.
Dennis Koh, Chief Strategic Growth Officer and Treasurer remarks: “We’re proud to have executed a successful transaction with participation from international investors for the first time. It’s a significant endorsement of the strength of our credit portfolio and our position in the healthcare finance sector. The demand received from investors demonstrates a clear appetite for high-quality Australian-origin assets.”
The transaction was rated by Moody’s and reflects the performance strength of the underlying portfolio.
Media contact
Lyndall Jenkins
lyndall.jenkins@credabl.com.au
02 9850 5362
